Sabra Health Care REIT earnings release, August 3, 2026

Sabra Health Care REIT, Inc. (SBRA) · Form 8-K, Item 2.02 · Filed · SEC filing

SABRA REPORTS SECOND QUARTER 2026 RESULTS; REITERATES 2026 GUIDANCE

TUSTIN, CA, August 3, 2026 — Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the second quarter of 2026.

SECOND QUARTER 2026 RESULTS AND RECENT EVENTS

• Results per diluted common share for the second quarter of 2026 were as follows:

• Net Loss: $(0.10)

• FFO: $(0.02)

• Normalized FFO: $0.38

• AFFO: $0.39

• Normalized AFFO: $0.40

• EBITDARM Coverage Summary:

• Skilled Nursing/Transitional Care: 2.49x

• Senior Housing - Leased: 1.52x

• Behavioral Health, Specialty Hospitals and Other: 4.14x

• On a year-over-year basis, same property managed senior housing Cash NOI increased 13.7% for the second quarter of 2026.

• In the second quarter of 2026, Sabra closed on several senior housing and skilled nursing investments for a total commitment of $274.1 million with an average initial cash yield of 8.1%.

• Subsequent to quarter end, Sabra closed on the acquisition of seven additional managed senior housing properties - including several value-add opportunities - for an aggregate price of $223.0 million. These investments have attractive embedded growth prospects and are expected to achieve unlevered IRRs in the teens.

• Investments closed year to date total $599.0 million, with an estimated initial cash yield of 7.5%.

• Sabra has been awarded an additional $100 million of managed senior housing and skilled nursing investments with an estimated initial cash yield of approximately 7.7%, all of which are expected to close by year end. These investments are currently in the Letter of Intent or later stage, and Sabra expects to fund these investments, if consummated, with available liquidity, including proceeds from outstanding forward sales agreements under its at-the-market equity offering program (“ATM program”).

• During the second quarter of 2026, Sabra exercised its option to reset the rent under its lease with the Avamere Family of Companies (“Avamere”) to a fixed amount tied to the portfolio’s historical performance. The reset increased annualized fixed cash rent to $48 million and was retroactive to February 1, 2026, which compares to $41 million of cash rent paid in 2025. The revised rent amount will be in effect until the Avamere transition outlined in Sabra's July 21, 2026, business update closes.

• During the second quarter of 2026, Sabra utilized the forward feature of the ATM program to allow for the sale of up to 0.9 million shares of the Company’s common stock at an initial weighted average price of $20.72 per share. As of June 30, 2026, 21.4 million shares remained outstanding under forward sale agreements at a weighted average price of $19.24 per share, net of commissions.¹

• As of June 30, 2026, Net Debt to Adjusted EBITDA was 4.61x.

• On August 3, 2026, Sabra’s Board of Directors declared a quarterly cash dividend of $0.30 per share of common stock. The dividend will be paid on August 31, 2026, to common stockholders of record as of the close of business on August 14, 2026.

• Sabra is also reiterating its full year 2026 guidance, which was included in Sabra’s July 21, 2026, business update.

Commenting on the second quarter’s results, Rick Matros, CEO and Chair, said, “Sabra delivered another solid quarter. Our same-store managed portfolio cash NOI growth continued to be healthy. Both our consolidated and unconsolidated managed portfolio came in with strong margin growth as well as increased occupancy. Our triple-net skilled nursing portfolio rent coverage increased yet again. The triple-net senior housing portfolio saw drops in occupancy and coverage simply due to the conversion of a high-performing triple-net asset to the managed portfolio. Otherwise, it would have been flat. In aggregate, our top ten tenants again showed increased coverage.

Sabra has now closed on approximately $600 million in investments this year, with another $100 million in the process of closing. Even with the addition of a few value-add opportunities, we are still getting transactions done at attractive yields. Our investment pipeline remains robust and consists almost entirely of senior housing opportunities. Our leverage, which was noted to be down to 4.8x in our recent business update, was 4.6x as of June 30. We look forward to a strong finish for the year.”

LIQUIDITY

As of June 30, 2026, we had approximately $1.3 billion of liquidity, consisting of unrestricted cash and cash equivalents of $231.6 million, available borrowings under our revolving credit facility of $682.5 million and $411.8 million related to shares outstanding under forward sale agreements under the ATM program. As of June 30, 2026, we also had $334.1 million available under our ATM program.

CONFERENCE CALL AND COMPANY INFORMATION

A conference call with a simultaneous webcast to discuss the 2026 second quarter results will be held on Tuesday, August 4, 2026, at 10:00 am Pacific Time. The webcast URL is https://events.q4inc.com/attendee/256627291. The dial-in number for U.S. participants is (888) 880-4448. For participants outside the U.S., the dial-in number is (646) 960-0572. The conference ID number is 1382596. A digital replay of the call will be available on the Company’s website at www.sabrahealth.com. The Company’s supplemental information package for the second quarter will also be available on the Company’s website in the “Investors” section.

ABOUT SABRA... (truncated)tments in loans receivable (consisting of one mortgage loans and 10 other loans), four preferred equity investments and two investments in unconsolidated joint ventures. As of June 30, 2026, Sabra’s real estate properties held for investment included 37,043 beds/units, spread across the United States and Canada.

Financial statements

Income Statement

Three Months Ended June 30, — (dollars in thousands, except per share data)

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025
Revenues:Rental and related revenues (1)101,30899,823196,358195,860
Revenues:Resident fees and services128,80278,985245,487156,432
Revenues:Interest and other income5,75610,34215,77420,401
Revenues:Total revenues235,866189,150457,619372,693
Expenses:Depreciation and amortization56,37943,586109,51087,080
Expenses:Interest29,77927,54858,18854,648
Expenses:Triple-net portfolio operating expenses3,6563,6987,4297,177
Expenses:Senior housing - managed portfolio operating expenses88,61657,404170,485113,858
Expenses:General and administrative16,81912,51431,68125,242
Expenses:Provision for (recovery of) loan losses and other reserves102,445-227102,232-400
Expenses:Impairment of real estate4,1034404,103
Expenses:Total expenses297,694148,626479,965291,708
Other income:Other (expense) income-2,68314,709-2,73814,747
Other income:Net gain on sales of real estate37,7179,97437,7179,974
Other income:Total other income35,03424,68334,97924,721
Other income:(Loss) income before income from unconsolidated joint ventures and income tax expense-26,79465,20712,633105,706
Other income:Income from unconsolidated joint ventures2,2248324,1361,050
Other income:Income tax expense-678-497-1,204-910
Other income:Net (loss) income-25,24865,54215,565105,846
Other income:Net loss attributable to noncontrolling interests46113
Other income:Net (loss) income attributable to Sabra Health Care REIT, Inc.-25,20265,54215,678105,846
Net (loss) income attributable to Sabra Health Care REIT, Inc., per:Basic common share-0.10.280.060.44
Net (loss) income attributable to Sabra Health Care REIT, Inc., per:Diluted common share-0.10.270.060.44
Net (loss) income attributable to Sabra Health Care REIT, Inc., per:Weighted average number of common shares outstanding, basic252,268,939237,976,314252,202,390237,933,910
Net (loss) income attributable to Sabra Health Care REIT, Inc., per:Weighted average number of common shares outstanding, diluted252,268,939240,929,866255,755,497240,711,387

Income Statement

Three Months Ended June 30, — (dollars in thousands, except per share data)

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025
Net (loss) income attributable to Sabra Health Care REIT, Inc.-25,20265,54215,678105,846
Add:Depreciation and amortization of real estate assets56,37943,586109,51087,080
Add:Depreciation and amortization of real estate assets related to noncontrolling interests-122-244
Add:Depreciation and amortization of real estate assets related to unconsolidated joint ventures1,4772,0433,0044,223
Add:Net gain on sales of real estate-37,717-9,974-37,717-9,974
Add:Impairment of real estate4,1034404,103
Add:FFO attributable to Sabra Health Care REIT, Inc.-5,185105,30090,671191,278
Add:Recoveries of straight-line rental income receivable and lease intangibles-1,613-1,463-1,468-1,463
Add:Provision for (recovery of) loan losses and other reserves102,445-227100,959-400
Add:Lease termination expense2,8732,873
Add:Other normalizing items (1)-290-14,451943-14,449
Add:Normalized FFO attributable to Sabra Health Care REIT, Inc.98,23089,159193,978174,966
Add:FFO attributable to Sabra Health Care REIT, Inc.-5,185105,30090,671191,278
Add:Stock-based compensation expense4,0892,7047,1875,415
Add:Non-cash rental and related revenues-3,654-3,903-5,253-6,331
Add:Non-cash interest expense2,3701,7264,7383,455
Add:Provision for (recovery of) loan losses and other reserves101,172-227100,959-400
Add:Other adjustments related to unconsolidated joint ventures7712815319
Add:Other adjustments (2)638-16,5281,145-16,082
Add:AFFO attributable to Sabra Health Care REIT, Inc.99,50789,200199,600177,354
Add:Lease termination expense2,8732,873
Add:Write-off of cash interest income receivable1,273
Add:Other normalizing items (1)-1932,4419292,525
Add:Normalized AFFO attributable to Sabra Health Care REIT, Inc.103,46091,641203,402179,879
Amounts per diluted common share attributable to Sabra Health Care REIT, Inc.:Net (loss) income-0.10.270.060.44
Amounts per diluted common share attributable to Sabra Health Care REIT, Inc.:FFO-0.020.440.350.79
Amounts per diluted common share attributable to Sabra Health Care REIT, Inc.:Normalized FFO0.380.370.760.73
Amounts per diluted common share attributable to Sabra Health Care REIT, Inc.:AFFO0.390.370.780.73
Amounts per diluted common share attributable to Sabra Health Care REIT, Inc.:Normalized AFFO0.40.380.790.74
Amounts per diluted common share attributable to Sabra Health Care REIT, Inc.:Weighted average number of common shares outstanding, diluted:Weighted average number of common shares outstanding, diluted:
Amounts per diluted common share attributable to Sabra Health Care REIT, Inc.:Net (loss) income and FFO252,268,939240,929,866255,755,497240,711,387

Balance Sheet

June 30, 2026 — (dollars in thousands, except per share data)

June 30, 2026December 31, 2025
AssetsReal estate investments, net of accumulated depreciation of $1,297,557 and $1,224,663 as of June 30, 2026 and December 31, 2025, respectively4,832,2554,686,377
AssetsLoans receivable and other investments, net115,078434,100
AssetsInvestment in unconsolidated joint ventures113,889118,166
AssetsCash and cash equivalents231,58471,537
AssetsRestricted cash6,7566,603
AssetsLease intangible assets, net82,95365,321
AssetsAccounts receivable, prepaid expenses and other assets, net130,095111,292
AssetsTotal assets5,512,6105,493,396
LiabilitiesSecured debt, net42,23343,275
LiabilitiesRevolving credit facility317,475217,584
LiabilitiesTerm loans, net1,029,5161,032,311
LiabilitiesSenior unsecured notes, net1,236,9401,235,726
LiabilitiesAccounts payable and accrued liabilities114,953119,329
LiabilitiesLease intangible liabilities, net19,05321,383
LiabilitiesTotal liabilities2,760,1702,669,608
EquityCommon stock, $0.01 par value; 500,000,000 shares authorized, 255,462,756 and 251,697,456 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively2,5552,517
EquityAdditional paid-in capital4,893,6534,836,270
EquityCumulative distributions in excess of net income-2,151,582-2,013,375
EquityAccumulated other comprehensive income (loss)6,097-3,571
EquityTotal Sabra Health Care REIT, Inc. stockholders’ equity2,750,7232,821,841
EquityNoncontrolling interests1,7171,947
EquityTotal equity2,752,4402,823,788
EquityTotal liabilities and equity5,512,6105,493,396

Cash Flow

Six Months Ended June 30, — (in thousands)

Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025
Cash flows from operating activities:Net income15,565105,846
Adjustments to reconcile net income to net cash provided by operating activities:Depreciation and amortization109,51087,080
Adjustments to reconcile net income to net cash provided by operating activities:Non-cash rental and related revenues-5,253-6,331
Adjustments to reconcile net income to net cash provided by operating activities:Non-cash interest income17
Adjustments to reconcile net income to net cash provided by operating activities:Non-cash interest expense4,7383,455
Adjustments to reconcile net income to net cash provided by operating activities:Stock-based compensation expense7,1875,415
Adjustments to reconcile net income to net cash provided by operating activities:Provision for (recovery of) loan losses and other reserves102,232-400
Adjustments to reconcile net income to net cash provided by operating activities:Net gain on sales of real estate-37,717-9,974
Adjustments to reconcile net income to net cash provided by operating activities:Impairment of real estate4404,103
Adjustments to reconcile net income to net cash provided by operating activities:Income from unconsolidated joint ventures-4,136-1,050
Adjustments to reconcile net income to net cash provided by operating activities:Distributions of earnings from unconsolidated joint ventures4,2204,022
Adjustments to reconcile net income to net cash provided by operating activities:Other non-cash items-17,190
Changes in operating assets and liabilities:Accounts receivable, prepaid expenses and other assets, net-11,922-6,867
Changes in operating assets and liabilities:Accounts payable and accrued liabilities-683-6,894
Changes in operating assets and liabilities:Net cash provided by operating activities184,182161,222
Cash flows from investing activities:Acquisition of real estate and lease intangibles-292,529-61,137
Cash flows from investing activities:Origination and fundings of loans receivable-994-3,110
Cash flows from investing activities:Origination and fundings of preferred equity investments-669-9
Cash flows from investing activities:Additions to real estate-25,160-13,569
Cash flows from investing activities:Escrow deposits for potential investments-400
Cash flows from investing activities:Repayments of loans receivable205,0817,048
Cash flows from investing activities:Repayments of preferred equity investments2,3461,369
Cash flows from investing activities:Investment in unconsolidated joint ventures-1,241
Cash flows from investing activities:Net proceeds from the sales of real estate93,6013,573
Cash flows from investing activities:Proceeds from net investment hedges4,462
Cash flows from investing activities:Insurance proceeds1361,038
Cash flows from investing activities:Net cash used in investing activities-18,588-61,576
Cash flows from financing activities:Net borrowings from revolving credit facility100,80055,144
Cash flows from financing activities:Principal payments on secured debt-1,066-1,038
Cash flows from financing activities:Payments of deferred financing costs-92-80
Cash flows from financing activities:Contributions from noncontrolling interests2
Cash flows from financing activities:Distributions to noncontrolling interests-119
Cash flows from financing activities:Payment of contingent consideration-1,178
Cash flows from financing activities:Issuance of common stock, net47,70524,211
Cash flows from financing activities:Dividends paid on common stock-151,314-142,754
Full release

FORWARD-LOOKING STATEMENTS SAFE HARBOR

This release contains “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995. Any statements that do not relate to historical or current facts or matters are forward-looking statements. These statements may be identified, without limitation, by the use of “expects,” “believes,” “intends,” “should” or comparable terms or the negative thereof. Examples of forward-looking statements include all statements regarding our other expectations regarding our future financial position (including our earnings guidance for 2026, as well as the assumptions set forth therein); our expectations regarding our results of operations, cash flows, liquidity, business strategy, growth opportunities, potential investments and dispositions; our expectations regarding our investment activity; our expectations regarding the proposed transition of the Avamere properties; and our plans and objectives for future operations.²

Our actual results may differ materially from those projected or contemplated by our forward-looking statements as a result of various factors, including, among others, the following: the ability to reach a definitive agreement for awarded investments and our ability to close such acquisitions on the expected terms or at all; our ability to complete the proposed transition of the Avamere properties on the expected terms or at all; increases in market interest rates and inflation; pandemics or epidemics, and the related impact on our tenants, borrowers and senior housing - managed communities; operational risks with respect to our senior housing - managed communities; increased labor costs and labor shortages; competitive conditions in our industry; the loss of key management personnel; uninsured or underinsured losses affecting our properties; potential impairment charges and adjustments related to the accounting of our assets; risks associated with our investment in our unconsolidated joint ventures; catastrophic weather and other natural or man-made disasters, the effects of climate change on our properties and a failure to implement sustainable and energy-efficient measures; increased operating costs and competition for our tenants, borrowers and senior housing - managed communities; increased healthcare regulation and enforcement; our tenants’ dependency on reimbursement from governmental and other third-party payor programs; the effect of our tenants, operators or borrowers declaring bankruptcy or becoming insolvent; our ability to find replacement tenants and the impact of unforeseen costs in acquiring new properties; the impact of litigation and rising insurance costs on the business of our tenants; the impact of required regulatory approvals of transfers of healthcare properties; environmental compliance costs and liabilities associated with real estate properties we own; our tenants’, borrowers’ or operators’ failure to adhere to applicable privacy and data security laws; a material breach of our or our tenants’, borrowers’ or operators’ information technology; our concentration in the healthcare property sector, particularly in skilled nursing/transitional care facilities and senior housing communities, which makes our profitability more vulnerable to a downturn in a specific sector than if we were investing in multiple industries; the significant amount of and our ability to service our indebtedness; covenants in our debt agreements that may restrict our ability to pay dividends, make investments, incur additional indebtedness and refinance indebtedness on favorable terms; adverse changes in our credit ratings; our ability to make dividend distributions at expected levels; our ability to raise capital through equity and debt financings; changes and uncertainty in macroeconomic conditions and disruptions in the financial markets; risks associated with our ownership of property outside the U.S., including currency fluctuations; the relatively illiquid nature of real estate investments; our ability to maintain our status as a real estate investment trust (“REIT”) under the federal tax laws; compliance with REIT requirements and certain tax and tax regulatory matters related to our status as a REIT; changes in tax laws and regulations affecting REITs; the ownership limits and takeover defenses in our governing documents and under Maryland law, which may restrict change of control or business combination opportunities; and the exclusive forum provisions in our bylaws.

Additional information concerning risks and uncertainties that could affect our business can be found in our filings with the Securities and Exchange Commission (the “SEC”), including in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025. We do not intend, and we undertake no obligation, to update any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, unless required by law to do so.

TENANT AND BORROWER INFORMATION

This release includes information regarding certain of our tenants that lease properties from us and our borrowers, most of which are not subject to SEC reporting requirements. The information related to our tenants and borrowers that is provided in this release has been provided by, or derived from information provided by, such tenants and borrowers. We have not independently verified this information. We have no reason to believe that such information is inaccurate in any material respect. We are providing this data for informational purposes only.... (truncated) MEASURES

This release includes the following financial measures defined as non-GAAP financial measures by the SEC: Net Debt to Adjusted EBITDA, funds from operations (“FFO”), Normalized FFO, Adjusted FFO (“AFFO”), Normalized AFFO, FFO per diluted common share, Normalized FFO per diluted common share, AFFO per diluted common share, Normalized AFFO per diluted common share, net operating income (“NOI”) and Cash NOI. These measures may be different than non-GAAP financial measures used by other companies, and the presentation of these measures is not intended to be considered in isolation or as a substitute for financial information prepared and presented in accordance with U.S. generally accepted accounting principles. An explanation of these non-GAAP financial measures is included under “Reporting Definitions” in this release, and reconciliations of these non-GAAP financial measures to the GAAP financial measures we consider most comparable are included on the Investors section of our website at https://ir.sabrahealth.com/investors/financials/quarterly-results.³

CONTACT

Investor & Media Inquiries: (888) 393-8248 or investorinquiries@sabrahealth.com⁴

SABRA HEALTH CARE REIT, INC.

CONSOLIDATED STATEMENTS OF (LOSS) INCOME

(dollars in thousands, except per share data)

(1)

See the following page for additional details regarding rental and related revenues.⁵

SABRA HEALTH CARE REIT, INC.

CONSOLIDATED STATEMENTS OF (LOSS) INCOME - SUPPLEMENTAL INFORMATION

(in thousands)⁶

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Sabra Health Care REIT earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.